Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

Paula K. Schweitzer(St Luke's Hospital), Kingman P. Strohl(University Hospitals of Cleveland), Atul Malhotra(Monash Health), Gary Zammit(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lawrence P. Carter(Jazz Pharmaceuticals (United States)), Russell Rosenberg(NeuroTrials Research (United States)), Dan Chen(Jazz Pharmaceuticals (United States)), Hao Wang(Jazz Pharmaceuticals (United States)), Yuan Lü(Jazz Pharmaceuticals (United States)), Jed Black(Jazz Pharmaceuticals (United States)), Mark H. Gotfried(Pulmonary Associates)
American Journal of Respiratory and Critical Care Medicine
December 6, 2018
10.1164/rccm.201806-1100oc
Cited by 316

Related Papers

Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events
|Journal of Clinical Sleep Medicine|2012|5.2k
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.
|PubMed|1999|3.7k
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
|Annals of Internal Medicine|1999|3k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Short Sleep Duration as a Risk Factor for Hypertension
|Hypertension|2006|1.2k